加速阿尔茨海默氏症Aβ-42二次核化在纤维表面上按时间顺序可视化
Peter Niraj Nirmalraj1, Shayon Bhattacharya2, Damien Thompson2
1Transport at Nanoscale Interfaces Laboratory, Swiss Federal Laboratories for Materials Science and Technology, Dübendorf, CH-8600, Switzerland.
Science advances
|October 25, 2024
概括
研究人员可视化了阿尔茨海默病纤维上有毒的粉样β (Aβ) 寡合体形成. 他们发现了具有高催化活性的"超扩散器"纤维,揭示了对蛋白质聚合的新见解.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 材料科学 材料科学 材料科学
背景情况:
- 蛋白纤维表面可以催化生成有毒的寡合物.
- 阿尔茨海默病与粉样β (Aβ) -42蛋白聚合有关.
- 基于光体的分析方法通常用于研究Aβ聚合.
研究的目的:
- 为了可视化和描述Aβ-42纤维表面上的二次核化事件.
- 了解纤维表面在加速聚合中的作用.
- 识别和分类不同的纤维素亚群.
主要方法:
- 基于液体的原子力显微镜用于纳米尺度成像.
- 原子规模的分子模拟.
- 量化纤维状尺寸变化和表面波纹的量化.
主要成果:
- 在所有纤维细胞阶段可视化了二次核化事件.
- 纤维边缘被确定为寡合体的首选结合点.
- 发现了一种具有高催化活性的"超级传播者"纤维素子群.
- 在终点阶段纤维素中观察到表面波纹的三倍增加,使得子群的分类成为可能.
结论:
- 基于液体的AFM和分子模拟为Aβ-42纤维素形成提供了新的见解.
- 识别超扩散纤维素为治疗策略提供了新的途径.
- 表面波纹可以用来分类Aβ纤维素亚群.
相关概念视频
Amyloid Fibrils
9.3K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.3K
Alzheimer's Disease: Overview
449
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
449


